Alpha Healthcare Acquisition Corp. III
ALPAW
NASDAQ Capital Market0.26
USD
-0.02
- -
Alpha Healthcare Acquisition Corp. III
ALPAW
(NASDAQ Capital Market)
Recent
price
0.26
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Alpha Healthcare Acquisition Corp. III (ALPAW) is a blank check company sponsored by Alpha Healthcare Acquisition Corp. III Sponsor LLC that seeks to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, primarily in the healthcare industry. The company targets healthcare companies across various subsectors, including biopharmaceuticals, medical devices, healthcare services, healthcare information technology, and healthcare-related consumer products; it offers no operational products or services prior to completing an initial business combination. Founded in 2023 and headquartered in New York, New York, Alpha Healthcare Acquisition Corp. III operates principally in the United States with a focus on North American and global healthcare targets. As of late 2025, the company remains in the pre-business combination phase with no publicly announced recent partnerships, acquisitions, funding rounds beyond its initial public offering, new product launches, strategic shifts, or operational changes within the last 1-2 years.